Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Outcomes of Chronic Lymphocytic Leukemia (CLL) Patients Treated With Venetoclax in Routine Clinical Settings in Greece

NCT04159779 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT04159779
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04159779 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Outcomes of Chronic Lymphocytic Leukemia (CLL) Patients Treated With Venetoclax in Routine Clinical Settings in Greece
Lead sponsor
AbbVie
Phase
Observational
Overall status
Active, not recruiting
Start date
January 13, 2020
Completion date
June 30, 2026
Enrollment
180 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia